231 related articles for article (PubMed ID: 19648094)
1. Vesicant chemotherapy extravasation antidotes and treatments.
Schulmeister L
Clin J Oncol Nurs; 2009 Aug; 13(4):395-8. PubMed ID: 19648094
[TBL] [Abstract][Full Text] [Related]
2. Antineoplastic vesicant extravasation.
Beason R
J Intraven Nurs; 1990; 13(2):111-4. PubMed ID: 2313459
[TBL] [Abstract][Full Text] [Related]
3. Vesicant extravasation: myths and realities.
Boyle DM; Engelking C
Oncol Nurs Forum; 1995; 22(1):57-67. PubMed ID: 7708525
[TBL] [Abstract][Full Text] [Related]
4. Managing vesicant extravasations.
Schulmeister L
Oncologist; 2008 Mar; 13(3):284-8. PubMed ID: 18378538
[TBL] [Abstract][Full Text] [Related]
5. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
Sauerland C; Engelking C; Wickham R; Corbi D
Oncol Nurs Forum; 2006 Nov; 33(6):1134-41. PubMed ID: 17149396
[TBL] [Abstract][Full Text] [Related]
6. European Oncology Nursing Society extravasation guidelines.
Wengström Y; Margulies A;
Eur J Oncol Nurs; 2008 Sep; 12(4):357-61. PubMed ID: 18765210
[TBL] [Abstract][Full Text] [Related]
7. Extravasation management.
Schulmeister L
Semin Oncol Nurs; 2007 Aug; 23(3):184-90. PubMed ID: 17693345
[TBL] [Abstract][Full Text] [Related]
8. Developing extravasation protocols and monitoring outcomes.
Camp-Sorrell D
J Intraven Nurs; 1998; 21(4):232-9. PubMed ID: 9866539
[TBL] [Abstract][Full Text] [Related]
9. Preventing and managing vesicant chemotherapy extravasations.
Schulmeister L
J Support Oncol; 2010; 8(5):212-5. PubMed ID: 21086879
[TBL] [Abstract][Full Text] [Related]
10. A flow sheet for follow-up after chemotherapy extravasation.
Davis ME; DeSantis D; Klemm K
Oncol Nurs Forum; 1995 Jul; 22(6):979-83. PubMed ID: 7567616
[TBL] [Abstract][Full Text] [Related]
11. Extravasation management: clinical update.
Schulmeister L
Semin Oncol Nurs; 2011 Feb; 27(1):82-90. PubMed ID: 21255716
[TBL] [Abstract][Full Text] [Related]
12. Anthracycline extravasations: prevention and management.
Roe H
Br J Nurs; 2011 Sep 22-Oct 13; 20(17):S16, S18-22. PubMed ID: 22067533
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological management of anticancer agent extravasation: A single institutional guideline.
Kimmel J; Fleming P; Cuellar S; Anderson J; Haaf CM
J Oncol Pharm Pract; 2018 Mar; 24(2):129-138. PubMed ID: 29284352
[TBL] [Abstract][Full Text] [Related]
14. Totect: a new agent for treating anthracycline extravasation.
Schulmeister L
Clin J Oncol Nurs; 2007 Jun; 11(3):387-95. PubMed ID: 17623623
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy extravasation from implanted ports.
Schulmeister L; Camp-Sorrell D
Oncol Nurs Forum; 2000 Apr; 27(3):531-8; quiz 539-40. PubMed ID: 10785905
[TBL] [Abstract][Full Text] [Related]
16. Dexrazoxane efficacy for anthracycline extravasation: use in UK clinical practice.
Muthuramalingam S; Gale J; Bradbury J
Int J Clin Pract; 2013 Mar; 67(3):244-9. PubMed ID: 23409691
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of saline washout technique in the management of exfoliant and vesicant chemotherapy extravasation: a historical case series report.
Harrold K; Gould D; Drey N
Eur J Cancer Care (Engl); 2013 Mar; 22(2):169-78. PubMed ID: 23320981
[TBL] [Abstract][Full Text] [Related]
18. [Extravasation of chemotherapeutic agents: prevention and therapy].
Jordan K; Grothe W; Schmoll HJ
Dtsch Med Wochenschr; 2005 Jan; 130(1-2):33-7. PubMed ID: 15619172
[TBL] [Abstract][Full Text] [Related]
19. [Introduction of a clinical protocol for extravasation at the National Institute of Oncology, Budapest, Hungary].
Bartal A; Mátrai Z; Rosta A; Szûcs A
Magy Onkol; 2011 Mar; 55(1):14-20. PubMed ID: 21617787
[TBL] [Abstract][Full Text] [Related]
20. Vesicant extravasation part II: Evidence-based management and continuing controversies.
Wickham R; Engelking C; Sauerland C; Corbi D
Oncol Nurs Forum; 2006 Nov; 33(6):1143-50. PubMed ID: 17149397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
